Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Dr. Krishna Ella
|
| gptkbp:country |
gptkb:India
|
| gptkbp:exportedTo |
over 123 countries
|
| gptkbp:focus |
vaccines
biopharmaceuticals |
| gptkbp:foundedBy |
Dr. Krishna Ella
|
| gptkbp:foundedIn |
1996
|
| gptkbp:headquarters |
Genome Valley, Hyderabad
|
| https://www.w3.org/2000/01/rdf-schema#label |
Bharat Biotech Hyderabad
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:location |
gptkb:Hyderabad
|
| gptkbp:manufacturingFacilities |
Genome Valley, Hyderabad
|
| gptkbp:notableFor |
developing Covaxin, India's indigenous COVID-19 vaccine
|
| gptkbp:numberOfEmployees |
over 1600
|
| gptkbp:product |
gptkb:Covaxin
gptkb:Rotavac gptkb:Typbar_TCV |
| gptkbp:researchArea |
infectious diseases
|
| gptkbp:subsidiary |
Bharat Biotech International Limited
|
| gptkbp:website |
https://www.bharatbiotech.com/
|
| gptkbp:bfsParent |
gptkb:Madhapur,_Hyderabad
|
| gptkbp:bfsLayer |
7
|